Co-Diagnostics, Inc.
CODX
$2.83
-$0.09-3.08%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 145.40K | 162.90K | 50.30K | 149.30K | 206.90K |
| Total Other Revenue | -- | -- | -- | 0.00 | 434.30K |
| Total Revenue | 145.40K | 162.90K | 50.30K | 149.30K | 641.10K |
| Cost of Revenue | 26.30K | 32.10K | 21.60K | 255.10K | 297.40K |
| Gross Profit | 119.10K | 130.80K | 28.70K | -105.70K | 343.70K |
| SG&A Expenses | 2.38M | 3.21M | 3.43M | 6.64M | 5.35M |
| Depreciation & Amortization | 267.40K | 291.40K | 280.40K | 357.10K | 351.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.16M | 8.22M | 8.60M | 12.06M | 10.88M |
| Operating Income | -7.01M | -8.06M | -8.55M | -11.91M | -10.23M |
| Income Before Tax | -7.05M | -7.72M | -7.52M | -11.04M | -9.67M |
| Income Tax Expenses | -1.17M | 12.30K | 12.00K | -8.20K | 22.20K |
| Earnings from Continuing Operations | -5.89M | -7.73M | -7.53M | -11.03M | -9.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.89M | -7.73M | -7.53M | -11.03M | -9.70M |
| EBIT | -7.01M | -8.06M | -8.55M | -11.91M | -10.23M |
| EBITDA | -6.75M | -7.77M | -8.27M | -11.55M | -9.88M |
| EPS Basic | -4.66 | -7.00 | -7.05 | -10.72 | -9.54 |
| Normalized Basic EPS | -3.49 | -4.56 | -5.00 | -7.19 | -6.12 |
| EPS Diluted | -4.80 | -7.00 | -7.20 | -10.77 | -9.60 |
| Normalized Diluted EPS | -3.49 | -4.56 | -5.00 | -7.19 | -6.12 |
| Average Basic Shares Outstanding | 1.26M | 1.10M | 1.07M | 1.03M | 1.02M |
| Average Diluted Shares Outstanding | 1.26M | 1.10M | 1.07M | 1.03M | 1.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |